Abstract
Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | M184-M203 |
| Journal | Investigative Ophthalmology and Visual Science |
| Volume | 60 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published (in print/issue) - 28 Feb 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Myopia control
- myopia progression
- clinical considerations
- patient communication
- practitioner education
Fingerprint
Dive into the research topics of 'IMI - Clinical Myopia Management Guidelines report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver